Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
Cytonus Therapeutics has raised $11.7M in total funding. The most recent round was Series A. The last funding was announced in November 2023.
Cytonus Therapeutics's investors include Creative Ventures, National Institutes of Health, Partners Investment, Wilson Sonsini Goodrich & Rosati, California Institute for Regenerative Medicine.
Cytonus Therapeutics is headquartered in Carlsbad, United States.
Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
Cytonus Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cytonus Therapeutics — Funding & Investors." VCBacked, November 3, 2023, https://www.vcbacked.co/company/cytonus-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Cytonus Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cytonus-therapeutics
{{cite web |title=Cytonus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cytonus-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated